M2 Presswire - Shareholders alert for Xenoport, Inc.
M2 PRESSWIRE-25 April 2007-Biotech News: Shareholders alert for Xenoport, Inc.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:25042007 Shareholders alert for Xenoport, Inc. (NASDAQ:XNPT) Xenoport, Inc. operates as a biopharmaceutical company in the United States. It focuses on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transporter mechanisms.
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
3 Questions No Job Seeker Ever Wants To Be Asked?
13 Job Interview Mistakes To Avoid
5 Regular Mistakes In Public Speaking
The company’s products include XP13512, a transported prodrug of gabapentin, which is in Phase 3 clinical trials for the treatment of restless legs syndrome; XP13512 for …
Read the rest of this article with a Free Trial at HighBeam Research.
